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Chlorpyrifos, one of the most widely used
organophosphorus pesticides, is increasingly
restricted in the United States because of its
adverse effects on fetal and neonatal brain
development [Barone et al. 2000; Landrigan
2001; Slotkin 2004; U.S. Environmental
Protection Agency (EPA) 2000, 2002].
Nevertheless, organophosphates, including
chlorpyrifos, still account for up to 50% of all
insecticide application worldwide (Casida and
Quistad 2004). Although the systemic toxic-
ity of these pesticides resides in their ability to
inhibit cholinesterase, other mechanisms con-
tribute to their developmental neurotoxicity,
notably the targeting of cell signaling cascades
governing neuronal and hormonal signals
that are essential to cell differentiation and
homeostatic regulation (Barone et al. 2000;
Casida and Quistad 2004; Gupta 2004; Pope
1999; Schuh et al. 2002; Slotkin 2004). Of
these, the pathway synthesizing cyclic AMP
(cAMP), controlled by adenylyl cyclase,
appears to be among the most prominent
sites for disruption by chlorpyrifos (Meyer
et al. 2003, 2004a, 2004b; Olivier et al.
2001; Ward and Mundy 1996; Zhang et al.
2002).
Adenylyl cyclase and cAMP also participate
in important metabolic, cardiovascular, and
hormonal functions in the periphery, and we
recently found that neonatal chlorpyrifos expo-
sure leads to disruption of cardiac and hepatic
cell signaling in adulthood (Meyer et al.
2004b). Perhaps most critically, chlorpyrifos-
exposed males showed hyperreactivity of
hepatic adenylyl cyclase to stimulation of
β-adrenoceptors or glucagon receptors, inputs
that are responsible for promoting gluco-
neogenesis and the consequent rise in circulat-
ing glucose levels. If these cellular alterations
do indeed result in changes in hepatic function
and responsiveness, then neonatal chlorpyrifos
exposure might be expected to elicit long-term
hyperglycemia and associated metabolic abnor-
malities, or alternatively, insulin hypersecretion
might be required to offset the promotion of
gluconeogenic signals. In the present study, we
demonstrate that male rats exposed neonatally
to chlorpyrifos display hyperinsulinemia and
hyperlipidemia in adulthood, two of the major
risk factors for type 2 diabetes mellitus and
atherosclerosis. Our working hypothesis thus
complements the Barker hypothesis, which
draws a connection between low birth weight
and the subsequent risk of coronary artery dis-
ease and diabetes (Barker 2003; Phillips 2002),
extending the same outcomes into the realm of
exposure to environmental toxicants even in
the absence of growth retardation.
Materials and Methods
Animal treatments. All experiments were car-
ried out in accordance with the Guide for the
Care and Use of Laboratory Animals as
adopted and promulgated by the National
Institutes of Health (Institute of Laboratory
Animal Resources 1996). Timed-pregnant
Sprague–Dawley rats (Charles River, Raleigh,
NC) were housed in breeding cages, with a
12/12 hr light/dark cycle and free access to
food and water. On the day of birth, all pups
were randomized and redistributed to the
dams with a litter size of 10 to maintain a
standard nutritional status. Randomization
within the respective treatment groups was
repeated at intervals of several days, and in
addition, dams were rotated among litters to
distribute any maternal caretaking differences
randomly across litters and treatment groups.
Chlorpyrifos (Chem Service, West Chester,
PA) was dissolved in dimethyl sulfoxide to
provide consistent absorption (Whitney et al.
1995) and was injected subcutaneously at a
dose of 1 mg/kg in a volume of 1 mL/kg once
daily on postnatal days 1–4; control animals
received equivalent injections of the dimethyl
sulfoxide vehicle. This regimen has been
shown previously to produce developmental
neurotoxicity without eliciting growth retar-
dation or any other signs of systemic toxicity
(Aldridge et al. 2004; Meyer et al. 2004a,
2004b; Slotkin 2004; Song et al. 1997;
Whitney et al. 1995). Indeed, neonatal brain
cholinesterase inhibition is only about 25%
(Song et al. 1997), well below the 70%
threshold necessary for symptoms of choliner-
gic hyperstimulation (Clegg and van Gemert
1999), thus resembling the nonsymptomatic
exposures reported in pregnant women
(De Peyster et al. 1993). Moreover, the dose
used here is well within the range of typical
fetal and childhood exposures after routine
application (Gurunathan et al. 1998; Ostrea
et al. 2002).
Animals were weaned on postnatal day 21.
Tests were performed using eight rats per sex
per treatment group, with no more than one
male and one female from each litter. Starting
immediately after weaning, animals were han-
dled every few days to accustom them to
removal from the cage and contact with the
investigators. At 110 days of age, during the
active (dark) cycle, animals were placed in a
Plexiglas restrainer, and two blood samples
(total volume, 500 µL) were obtained from
each animal by tail vein venipuncture, using a
23-gauge butterfly, one without added anti-
coagulant and the other containing EDTA.
Handling was then maintained for the ensuing
10 days, at which time animals were fasted
8 hr, and a second pair of samples were
Environmental Health Perspectives • VOLUME 113 | NUMBER 10 | October 2005 1291
Research
Address correspondence T.A. Slotkin, Box 3813
DUMC, Duke University Medical Center, Durham,
NC 27710 USA. Telephone: (919) 681-8015. Fax:
(919) 684-8197. E-mail: t.slotkin@duke.edu
This work was supported by National Institutes of
Health grants ES10387 and ES10356.
The authors declare they have no competing
ﬁnancial interests. 
Received 21 March 2005; accepted 2 June 2005.
Developmental Exposure of Rats to Chlorpyrifos Elicits Sex-Selective
Hyperlipidemia and Hyperinsulinemia in Adulthood
Theodore A. Slotkin,1 Kathleen K. Brown,2 and Frederic J. Seidler1
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA; 2GlaxoSmithKline Inc.,
Research Triangle Park, North Carolina, USA
Developmental exposure to chlorpyrifos alters cell signaling both in the brain and in peripheral
tissues, affecting the responses to a variety of neurotransmitters and hormones. We administered
1 mg/kg/day chlorpyrifos to rats on postnatal days 1–4, a regimen below the threshold for sys-
temic toxicity. When tested in adulthood, chlorpyrifos-exposed animals displayed elevations in
plasma cholesterol and triglycerides, without underlying alterations in nonesteriﬁed free fatty acids
and glycerol. This effect was restricted to males. Similarly, in the postprandial state, male rats
showed hyperinsulinemia in the face of normal circulating glucose levels but demonstrated appro-
priate reduction of circulating insulin concentrations after fasting. These outcomes and sex selec-
tivity resemble earlier ﬁndings at the cellular level, which identiﬁed hepatic hyperresponsiveness to
gluconeogenic inputs from β-adrenoceptors or glucagon receptors. Our results thus indicate that
apparently subtoxic neonatal chlorpyrifos exposure, devoid of effects on viability or growth but
within the parameters of human fetal or neonatal exposures, produce a metabolic pattern for
plasma lipids and insulin that resembles the major adult risk factors for atherosclerosis and type 2
diabetes mellitus. Key words: Barker hypothesis, chlorpyrifos, cholesterol, diabetes mellitus type 2,
insulin, organophosphates, triglycerides. Environ Health Perspect 113:1291–1294 (2005).
doi:10.1289/ehp.8133 available via http://dx.doi.org/ [Online 2 June 2005]obtained. Sera were analyzed using an
Olympus Au640 Clinical Chemistry Analyzer
(Olympus America Inc., Melville, NY), and
insulin was determined using a commercial
radioimmunoassay kit (Linco Research, St.
Charles, MO). Samples containing EDTA
were analyzed for total and glycosylated hemo-
globin using a ColumnMate Analyzer (Helena
Laboratories, Beaumont, TX). At no time dur-
ing the restraint or venipuncture did the ani-
mals show overt signs of distress such as
struggling or vocalizations.
Data analysis. Data are presented as
means and standard errors. To establish the
effects of chlorpyrifos and its relationship to
other variables, a multivariate analysis of vari-
ance (ANOVA; data log-transformed because
of heterogeneous variance) was first con-
ducted, encompassing neonatal treatment,
sex, and feeding status (nonfasted vs. fasted,
treated as a repeated measure, because each
animal was evaluated sequentially for both
states). Where chlorpyrifos treatment inter-
acted with the other variables, data were then
subdivided to permit lower-order ANOVAs,
followed where appropriate by Fisher’s pro-
tected least significant difference to identify
individual values for which the chlorpyrifos
groups differed from the corresponding con-
trol; however, in the absence of interactions,
only main chlorpyrifos treatment effects are
reported. For all tests, significance was
assumed at p < 0.05.
Results and Discussion
Neonatal chlorpyrifos exposure had no effect
on growth or viability (data not shown), or on
body weights of male or female rats in adult-
hood, nor were there any significant altera-
tions in plasma levels of nonesteriﬁed free fatty
acids or glycerol (Table 1). Nevertheless, cho-
lesterol and triglycerides displayed signiﬁcant
elevations that were distinctly sex selective
(treatment × sex interaction, p < 0.03), with a
preferential effect in males (Figure 1). Both
cholesterol and triglycerides were increased by
about 35%, an effect that persisted even when
the animals were fasted.
In contrast to the robust effect on plasma
lipids, glucose concentrations in chlorpyrifos-
exposed animals remained entirely within the
normal range for either males or females
(Figure 2A), nor did we see any change in the
percentage of glycosylated hemoglobin (data
not shown). The chlorpyrifos group also
showed the typical reduction in glucose levels
when fasted and values for females were lower
than for males, just as in the control group.
Nevertheless, the concentration of insulin was
markedly elevated in nonfasted male rats,
> 60% higher than in controls (Figure 2B).
Fasting restored the insulin level to normal. In
contrast, female rats exposed to chlorpyrifos
did not show an elevation in insulin and
actually showed a slight decrease at the margin
of statistical signiﬁcance. The normal sex dif-
ferences in these measures as seen in the con-
trol groups reproduce those reported
previously (O’Regan et al. 2004).
Our results thus indicate that apparently
subtoxic neonatal chlorpyrifos exposure,
devoid of effects on viability or growth and
within the parameters of human fetal or
neonatal exposures, produces a metabolic pat-
tern for plasma lipids and insulin that resem-
bles the known major risk factors and
predictors for the appearance of athero-
sclerosis and type 2 diabetes mellitus in adult-
hood (Davis and Edelman 2004; Reaven et al.
2004). The sex selectivity and response to
fasting both point to specific mechanisms
underlying these effects. In our earlier work,
we found that neonatal chlorpyrifos exposure
produces hyperresponsiveness of hepatic cell
signaling mediated through adenylyl cyclase,
an effect specific to males (Meyer et al.
2004b). The promotional effect extends to
two receptors linked to gluconeogenesis, the
β-adrenoceptor and the glucagon receptor,
and accordingly, it might be expected that
these animals would show hyperglycemia.
However, as shown here, circulating glucose
levels remain essentially normal but only
because the effects on gluconeogenic signals
are offset by a sustained elevation in post-
prandial circulating insulin concentrations.
This counterbalanced relationship is rein-
forced by the fact that fasting restored insulin
levels to normal: the feedback regulation of
insulin release in response to reduced glucose
availability during fasting is intact in the chlor-
pyrifos group. Under normal dietary condi-
tions, the chlorpyrifos-exposed animals thus
display hyperinsulinemia, a characteristic of
the prediabetic state in type 2 diabetes melli-
tus, particularly in obese individuals (Davis
Slotkin et al.
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Table 1. Body weights, nonesteriﬁed free fatty acids, and glycerol.
Male Female
Measure, age, and feeding status Control Chlorpyrifos Control Chlorpyrifos
Body weight (g)
110 days, fed 539 ± 19 547 ± 19 301 ± 7 298 ± 9
120 days, fasted 548 ± 16 568 ± 20 317 ± 6 302 ± 9
Nonesteriﬁed free fatty acids (µEq/dL)
110 days, fed 70 ± 14 67 ± 11 60 ± 8 87 ± 14
120 days, fasted 116 ± 9 112 ± 9 121 ± 11 130 ± 8
Glycerol (mg/dL)
110 days, fed 24 ± 3 22 ± 3 26 ± 2 31 ± 3
120 days, fasted 28 ± 2 25 ± 1 31 ± 1 27 ± 1
µEq, microequivalents. Values shown are mean ± SE. ANOVA for each set of measures indicates no signiﬁcant treatment
differences. By itself, fasting increased nonesteriﬁed free fatty acids (main effect of feeding status, p < 0.0001); glycerol
values in females were signiﬁcantly higher overall than in males (main effect of sex, p < 0.03).
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Figure 1. Effects of neonatal chlorpyrifos exposure on plasma lipids in adulthood. NS, not significant.
Values shown are mean ± SE. ANOVA across all measures, feeding status, and sex appears at the top;
data were subdivided into males and females because of the signiﬁcant treatment × sex interaction. The
main chlorpyrifos treatment effect for each sex is shown within the panel; separate lower-order tests for
cholesterol or triglycerides in fed and fasted states were not carried out because of the absence of inter-
actions of treatment × feeding status or treatment × lipid subtype. Note the different scales for cholesterol
and triglycerides. and Edelman 2004; Reaven et al. 2004); how-
ever, in this case, the hyperinsulinemia exists
even in animals with a normal body weight.
Just as found for insulin, male rats exposed
to neonatal chlorpyrifos showed elevated
plasma cholesterol and triglycerides in adult-
hood, thus sharing one of the major risk fac-
tors for human atherosclerosis. Furthermore,
elevated postprandial triglycerides are yet
another component of the metabolic syn-
drome that confers a signiﬁcant risk of vascu-
lar disease. In the present study, there was no
evidence of increased in vivo lipolysis (i.e.,
insulin resistance at the level of the adipocyte)
because nonesteriﬁed fatty acids and glycerol
were within normal limits. Unlike the situa-
tion for insulin, fasting did not reverse the
effects on plasma cholesterol and triglycerides,
likely reﬂecting their longer biologic half-life.
Again, the main finding is that an otherwise
subtoxic developmental exposure to chlorpyri-
fos leads to hyperlipidemia similar to that
found in individuals prone to cardiovascular
disease.
The present results point to a distinct sex
disparity in the metabolic consequences of
neonatal chlorpyrifos exposure, findings in
keeping with effects on hepatic cell signaling
as reported previously (Meyer et al. 2004b).
Indeed, many other aspects of the develop-
mental toxicity of chlorpyrifos similarly dis-
play sex differences, including neurochemical
and behavioral effects (Aldridge et al. 2004,
2005; Levin et al. 2001; Moser et al. 1998).
The speciﬁc mechanisms underlying the tar-
geting of males or females is not yet known,
but it is important to note that the impact on
brain development targets both males and
females, albeit with different patterns of
effects. In contrast, the present results indicate
metabolic effects restricted to males, so it is
unlikely that the underlying mechanisms are
the same as those involved in the neurobehav-
ioral effects of chlorpyrifos. In keeping with
the present ﬁndings, many other developmen-
tal disruptors similarly produce sexually
dimorphic changes in cardiovascular and/or
metabolic outcomes in males and females,
both in animal studies and in humans (Adair
and Cole 2003; Khan et al. 2003; O’Regan
et al. 2004). Taken together with our find-
ings, sex differences clearly need to be taken
into account in future evaluations of similar
outcomes from developmental chlorpyrifos
exposure.
In its original formulation, the Barker
hypothesis related prenatal factors leading to
reduced birth weight with the subsequent
development of cardiovascular disease and
diabetes (Barker 2003). The present results
point to similar outcomes evoked by an
apparently “safe” exposure to a common
environmental toxicant, even when normal
growth parameters are maintained. In con-
junction with our earlier ﬁndings for effects of
neonatal chlorpyrifos exposure on hepatic cell
signaling related to metabolic function
(Meyer et al. 2004b), we can now provide a
mechanistic link between cellular events and
the appearance of hyperinsulinemia and
hyperlipidemia in adulthood. Of course,
because atherosclerosis and type 2 diabetes are
multifactorial diseases, it is unlikely that
chlorpyrifos exposure by itself would elicit
these disease outcomes; nevertheless, the fact
that chlorpyrifos evokes two of the metabolic
changes most highly associated with these dis-
eases implies that such exposures may increase
risk or vulnerability to other contributory
components. The standard view of chlorpyri-
fos, and potentially other organophosphorus
insecticides, as developmental toxicants that
specifically target the nervous system may
thus require substantial revision.
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